ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
11/20/2024
Back to search
Official data from USPTO
BLINDDATE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
BLINDDATE
ST13
US500000090572021Class
5, 42
Filing
90572021
Registration
6637024
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
11/20/2024
Classification
Registered
Trademark type
Word
Nice classes
5, 42
Filing date
03/10/2021
Registration date
02/08/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/08/2022
Last transaction
02/08/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Abingdon, Oxfordshire, GB
Examiner
HUSSAIN, TASNEEM
Law office
M90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Immunocore Limited
Representatives
ANDREW D. PRICE VENABLE LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of cancerviral infectionsautoimmune diseasestumorous diseases; biological preparations for the treatment of viral infections; biological preparations for the treatment of autoimmune diseases; biological preparations for medical use for the treatment of tumorous diseases; immunotherapeutic drugspharmaceutical preparations for the treatment of cancerviral infectionsautoimmune diseasestumorous diseases; reagents for medical use; diagnostic preparations for medical purposes; diagnostic reagents for medical use; medical diagnostic reagents used in connection with drug discoverythe identification of pharmaceutical targets and the development of molecules to be used for medicinal or therapeutic purposes; medical diagnostic reagents used in connection with protein engineering and biological drug development
Class 42
Scientific and technological servicespharmaceutical research and design relating thereto; pharmaceutical research and development services; pharmaceutical testing and clinical trials; research and development in the biotechnology field; drug discoverythe identification of pharmaceutical targets and the development of molecules to be used for medicinal or therapeutic purposes; protein engineering and biological drug development; provision of information and consultancy in relation to the aforesaid services
Publications
History of USPTO decisions and trademark events.
19 publications found
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
12/28/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
02/08/2022
ISPO
WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST
11/30/2021
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
11/24/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/23/2021
PUBO
PUBLISHED FOR OPPOSITION
11/23/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/03/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/19/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
10/06/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/06/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
10/06/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/06/2021
DOCK
ASSIGNED TO EXAMINER
10/04/2021
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
06/24/2021
ALIE
ASSIGNED TO LIE
06/17/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/10/2021
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
03/29/2021
NWAP
NEW APPLICATION ENTERED
03/13/2021
Continuous trademark protection
Get notified about every new filing that threatens BLINDDATE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.